0001127602-19-027064.txt : 20190820 0001127602-19-027064.hdr.sgml : 20190820 20190820161731 ACCESSION NUMBER: 0001127602-19-027064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190816 FILED AS OF DATE: 20190820 DATE AS OF CHANGE: 20190820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Humphries William D. CENTRAL INDEX KEY: 0001674278 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 191039701 MAIL ADDRESS: STREET 1: C/O CLEARSIDE BIOMEDICAL, INC. STREET 2: 1220 OLD ALPHARETTA ROAD, SUITE 300 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-08-16 0000885590 Bausch Health Companies Inc. BHC 0001674278 Humphries William D. 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 President, Ortho-Dermatologics Common Stock, No Par Value 2019-08-16 4 P 0 30703 21.1752 A 147721 D Common Stock, No Par Value 2019-08-16 4 A 0 30703 0 A 178424 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.13 to $21.18 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote. Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported on Table I (the "Purchased Shares"), pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second and third anniversaries following the date of grant ("MRSU Grant Date"), subject to the Reporting Person's continued service (except in limited circumstances). /s/ Kirsten O'Donnell, attorney-in-fact for William D. Humphries 2019-08-20